EUVIMEDEUVIMED entdecken
Crossref

The Early Clues of Infantile Hemangiomas: Identifying Subtle Signs and Avoiding Diagnostic Delay

Emily Garelick, Morgan Ulczak, Ruby Garcia, Danny Lee, Gili Amid-Toby, Kelly Fraiser, Adriana Lombardi

Journal of Dermatology Research · 06.07.2026 · 7 (2) · 1-10

DOI: 10.46889/jdr.2026.7208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Dermatology Research, online erschienen am 06.07.2026. Verfasst von Emily Garelick und 6 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose of the Study: Infantile Hemangiomas (IHs) are the most common benign vascular tumors of infancy, affecting 2-10% of children. Although many lesions regress spontaneously, 10-15% develop complications such as ulceration, airway obstruction, visual impairment or cardiac failure. Because most growth occurs before three months of age, early recognition and referral are critical; however, delays in diagnosis remain common. This review aimed to identify early clinical signs of IHs, summarize diagnostic challenges and evaluate tools that support timely recognition and referral. Methodology: A PRISMA-guided scoping review was conducted using PubMed on August 17, 2025. Primary studies published between 2015 and 2025 involving infants or children with IHs were eligible for inclusion. Of 1,279 records identified, 24 studies met inclusion criteria following screening and exclusion of irrelevant articles. Key Findings: Infantine hemangiomas were most commonly recognized within the first days to three months of life. Early indicators included red or bluish lesions and premonitory signs such as pale macules, telangiectasia and bruise-like patches. In select cases, presenting symptoms included feeding difficulties, respiratory distress, hepatomegaly or neurologic deficits. Imaging modalities were primarily utilized for complex or atypical lesions. Several studies emphasized the importance of distinguishing IHs from vascular and nonvascular mimickers. High-risk IHs often required treatment, with oral propranolol identified as the first-line therapy. Emerging referral tools and artificial intelligence-based diagnostic approaches demonstrated potential to improve. Conclusion: Recognition of subtle early findings, particularly premonitory cutaneous changes, is essential for timely diagnosis of IHs. Increased provider and caregiver education, implementation of standardized screening and referral tools and continued research into novel diagnostic technologies may help reduce delays in care and improve patient outcomes.

Zitieren

APA

Garelick, E., Ulczak, M., Garcia, R., Lee, D., Amid-Toby, G., Fraiser, K., & Lombardi, A. (2026). The Early Clues of Infantile Hemangiomas: Identifying Subtle Signs and Avoiding Diagnostic Delay. Journal of Dermatology Research, 7(2), 1-10. https://doi.org/10.46889/jdr.2026.7208

Vancouver

Garelick E, Ulczak M, Garcia R, Lee D, Amid-Toby G, Fraiser K, et al. The Early Clues of Infantile Hemangiomas: Identifying Subtle Signs and Avoiding Diagnostic Delay. Journal of Dermatology Research. 2026;7(2):1-10. doi:10.46889/jdr.2026.7208

BibTeX
@article{Garelick2026,
  author = {Garelick, Emily and Ulczak, Morgan and Garcia, Ruby and Lee, Danny and Amid-Toby, Gili and Fraiser, Kelly and Lombardi, Adriana},
  title = {The Early Clues of Infantile Hemangiomas: Identifying Subtle Signs and Avoiding Diagnostic Delay},
  journal = {Journal of Dermatology Research},
  year = {2026},
  volume = {7},
  number = {2},
  pages = {1--10},
  doi = {10.46889/jdr.2026.7208}
}
Kostenlos starten →